Загрузка видео...

Не удалось загрузить видео

На главную

Dr. Patrick Soon-Shiong just showed Chris Cuomo dramatic before-and-after brain scans of late-stage tumor patients who failed chemo, radiation, and surgery — achieving complete remission with ANKTIVA. No chemo. No radiation. Tumors shrinking dramatically in months. He says: “We got FDA approval to treat patients who failed everything… and...

282,229 просмотров • 6 месяцев назад •via X (Twitter)

Комментарии: 35

Фото профиля Camus
Camus6 месяцев назад

Credit: @DrPatrick; @NewsNation;

Фото профиля Holistic Health
Holistic Health6 месяцев назад

Very promising. I recommend watching his long form interview with Tucker.

Фото профиля Jeff Boone
Jeff Boone6 месяцев назад

Keep this man safe. The drug companies don't like cures, just endless treatments.

Фото профиля freedom🇨🇦
freedom🇨🇦6 месяцев назад

I used to follow Patrick until I noticed he never mentions cheap, repurposed drugs like ivermectin, mebendazole, or fenbendazole. This is a red flag for me, but I hope he succeeds and can make Anktiva affordable. Unfortunately, Anktiva is what Scott Adams took shortly before he rapidly deteriorated and died. @MakisMedicine

Фото профиля Berlinergy
Berlinergy6 месяцев назад

Yes +check the latest presentation of patient results (before after )here :

Фото профиля Sandy Glass
Sandy Glass6 месяцев назад

My daughter needs to have ANKTIVA to help replenish her leukocyte count destroyed by chemo. ANKTIVA non-toxic, studied for over 10 years but FDA slow walking approval. Why?

Фото профиля thedude
thedude6 месяцев назад

are you folks insane, lol,, this guy is classic big pharma: Soon-Shiong is the chairman of Chan Soon-Shiong Family Foundation, a non-profit foundation. He has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and executive chairman of the Los Angeles Times.[6] Soon-Shiong's net worth is estimated at US$16.6 billion as of 2026 according to the Bloomberg Billionaires Index and Forbes.[7] He has been called the richest man in Los Angeles and one of the wealthiest doctors in the world.[8]

Фото профиля Carlos_Danger
Carlos_Danger6 месяцев назад

Why not give this to anyone that's terminal who wants it and use that as trials? My father died from gallbladder cancer. He was late stage 4 when diagnosed. They pumped every poison in his body for six months trying to slow the inevitable. I think it actually sped it up, but we would have gladly taken this if offered.

Фото профиля Chalala🐾🇺🇸
Chalala🐾🇺🇸6 месяцев назад

My daughter has brain cancer and has completed radiation and chemo. The chemo has caused her to need three blood transfusions. She should have access to Anktiva. @RobertKennedyJr @US_FDA

Фото профиля Gary
Gary6 месяцев назад

@XrpHomie $IBRX If anyone hasn’t seen the @NewsNation @ChrisCuomo interview with @DrPatrick, it’s a must watch. Dr. Patrick has shown amazing results on many cancers-patient testimonies at 40 min mark-Aline and Jim- all current had failed until Anktiva-Miracle🙏

Фото профиля BrianSays
BrianSays6 месяцев назад

Lost my mom to brain cancer is 2019. I hope this proves helpful to those suffering from this horrendous disease

Фото профиля Janet Neustedter
Janet Neustedter6 месяцев назад

Good information but anything with @ChrisCuomo in it is automatic cringe. He is a tool now and then and has zero credibility

Фото профиля MysteryMavX
MysteryMavX6 месяцев назад

Fabulous! It should be available immediately, not just late-stage, nothing else works. Why go through all those horrific treatments if this is better?

Фото профиля Brad C
Brad C6 месяцев назад

The @US_FDA needs to allow this in the US. The fact Saudi Arabia is allowing this but we can’t have this treatment in the US. Because big pharma takes priority is ridiculous.

Фото профиля Gary Gerden
Gary Gerden6 месяцев назад

@bullishbruk If the medical establishment wasn’t already making billions of the chemotherapy, this treatment would be fast tracked for FDA approval.

Фото профиля Marsha Flewelling
Marsha Flewelling6 месяцев назад

Right to Try

Фото профиля DougW
DougW6 месяцев назад

Chris Cuomo can kiss my ass! I have detested him since he and his lowlife brother were the biggest supporters of Herr Fauci and the illegal Bribum mandates! I am familiar with the great doctor Dr. Patrick Soon-Shiong but just wish he wouldn't give that bum a second of his time.

Фото профиля Dr. Tamale Henry Duke
Dr. Tamale Henry Duke6 месяцев назад

This is groundbreaking! The potential of ANKTIVA could change cancer treatment entirely. Looking forward to more updates on this progress.

Фото профиля Macaroniste
Macaroniste6 месяцев назад

Didn't work for Scott Adams, though.

Фото профиля TruthS33ker🐭
TruthS33ker🐭6 месяцев назад

Oh my … so much to learn …. Soon-Shiong is so much more than most realize 💥💥🧵👇👇

Фото профиля MP
MP6 месяцев назад

A family member received the Anktiva shot. Shortly after, blood test numbers went out of normal range. When they didn't return to normal by the time he was supposed to receive the second shot, they kicked him out of the trial. Surely your success members look good when you immediately remove people who aren't doing well from the program. This family member was currently doing another standard treatment for his cancer and his continues to do well on that without the Anktiva. Hard to believe this is much more than snake oil.

Фото профиля UnitedWeStand-DividedWeFall
UnitedWeStand-DividedWeFall6 месяцев назад

Now look into the cost of treatment. Is Not of the cost covered? Millionaires congrats. You found a cure.

Фото профиля SpilDaBeans
SpilDaBeans6 месяцев назад

Please explain why people have to go through hell before they can receive Anktiva. Why do patients have to be in late stage?

Фото профиля klemens d
klemens d6 месяцев назад

I don't trust the guy as far as I can throw him. I wouldn't be suprised if his super expensive biologicals contained a healthy dose of fenbendazole and ivermectin on the side.

Фото профиля kelly
kelly6 месяцев назад

This should be for all stage- Not just late stage!

Фото профиля Jackie Beal
Jackie Beal6 месяцев назад

I’m hoping it is a cure but it must not always be as Scott Adams used it and still died

Фото профиля Wendi Strauch Mahoney🇺🇸Persevere.
Wendi Strauch Mahoney🇺🇸Persevere.6 месяцев назад

@WorkAuthority I wonder if it works on multiple myeloma

Фото профиля Bryn Stables 🇳🇿 颜领惠
Bryn Stables 🇳🇿 颜领惠6 месяцев назад

Absolutely need larger and longer term trials! Otherwise same issue as Covid vaccine. There is no replacement for time to show harms.

Фото профиля Asbury4040
Asbury40406 месяцев назад

Look into the @FLsharkman protocols. It’s the only thing I currently trust.

Фото профиля Cj Stites
Cj Stites6 месяцев назад

@megbasham please help her

Фото профиля Sera Aurelia X
Sera Aurelia X6 месяцев назад

This guy is a grifter. Many previous similar projects. Caution.

Фото профиля kerrie Tu
kerrie Tu6 месяцев назад

How long before this outspken person os gone

Фото профиля Waltz King
Waltz King6 месяцев назад

@JRPLawyeress Big Pharma will kill it!

Фото профиля Kathy
Kathy6 месяцев назад

I’m stage 4 stomach cancer and I want it now!

Фото профиля Rachel Buckley
Rachel Buckley6 месяцев назад

Saudi Arabia allows this treatment so why can't we in the US?

Похожие видео

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 просмотров • 8 месяцев назад

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.

Camus

422,251 просмотров • 11 месяцев назад

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,893 просмотров • 1 год назад

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Camus

38,936 просмотров • 1 год назад

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 просмотров • 1 год назад